← Leaderboards
Tomas Ganz
University Of California Los Angeles
$17,717,559
Attributed
$21,677,120
Total exposure
16
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,931,121 · 17
By mechanism
R01$15,382,162 · 7
T32$4,816,268 · 1
U2C$2,254,001 · 1
R21$878,274 · 2
P50$386,712 · 1
P01$159,697 · 2
Top collaborators
- Steven M. Dubinett10 shared
- Stefano Rivella5 shared
- Isidro B. Benjamin Salusky5 shared
- Stephen Jay Freedland4 shared
- Jennifer Tash Anger1 shared
- John A Belperio1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Adriana Galvan$3,459,523
- Tara S Peris$3,024,577
- Manuel L Penichet$9,583,462
- Judith E Carroll$5,079,156
- Helen Lavretsky$17,053,369
Others in their field
Top investigators on “Iron Metabolism”
- Edward I Solomon · Stanford University$15,942,973
- James A. Imlay · University Of Illinois Urbana-Champaign$14,755,956
- Jerry Kaplan · University Of Utah$12,849,658
- Michael K. Georgieff · University Of Minnesota Twin Cities$11,827,899
- Stephania A Cormier · Louisiana State Univ A&M Col Baton Rouge$11,241,720
- Gary M Brittenham · Weill Medical Coll Of Cornell Univ$10,745,978
Research focus
Iron MetabolismAnemiaIronHepcidinMetal Transporting Protein 1Iron OverloadProgramsHomeostasisHematologyErythrocytesHuman SubjectHepatocyteInflammationResponseErythropoiesisPeptidesPathogenesisChronicMacrophageMolecularProductionBaseAmino AcidsInsight
Grant awards (74)
The UCLA Pulmonary and Critical Care Medicine Scientist Training Program (PCCM-STP)$530,877
T32 · FY2025 · HL
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$460,000
U2C · FY2025 · DK
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$458,477
R01 · FY2024 · DK · contact PI
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$414,001
U2C · FY2024 · DK
UCLA Pulmonary and Critical Care Medicine Training Program$279,387
T32 · FY2024 · HL
UCLA Pulmonary and Critical Care Medicine Training Program$582,670
T32 · FY2023 · HL
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$477,581
R01 · FY2023 · DK · contact PI
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$460,000
U2C · FY2023 · DK
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$477,581
R01 · FY2022 · DK · contact PI
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$460,000
U2C · FY2022 · DK
UCLA Pulmonary and Critical Care Medicine Training Program$400,415
T32 · FY2022 · HL
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$107,177
R01 · FY2022 · DK · contact PI
UCLA Pulmonary and Critical Care Medicine Training Program$544,458
T32 · FY2021 · HL
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$477,581
R01 · FY2021 · DK · contact PI
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$460,000
U2C · FY2021 · DK
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$89,315
R01 · FY2021 · DK · contact PI
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$17,862
R01 · FY2021 · DK · contact PI
UCLA Pulmonary and Critical Care Medicine Training Program$536,332
T32 · FY2020 · HL
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS$477,581
R01 · FY2020 · DK · contact PI
Pulmonary and Critical Care Medicine Training Program$207,526
T32 · FY2018 · HL
Pulmonary and Critical Care Medicine Training Program$391,515
T32 · FY2017 · HL
The role of erythroferrone in iron homeostasis and in iron-loading anemias$334,950
R01 · FY2017 · DK · contact PI
Pulmonary and Critical Care Medicine Training Program$484,517
T32 · FY2016 · HL
The role of erythroferrone in iron homeostasis and in iron-loading anemias$334,950
R01 · FY2016 · DK · contact PI
Pulmonary and Critical Care Medicine Training Program$470,883
T32 · FY2015 · HL
The role of erythroferrone in iron homeostasis and in iron-loading anemias$334,950
R01 · FY2015 · DK · contact PI
Hepcidin therapy for iron overload and hematologic disorders$553,241
R01 · FY2014 · DK
Pulmonary and Critical Care Medicine Training Program$387,688
T32 · FY2014 · HL
The role of erythroferrone in iron homeostasis and in iron-loading anemias$334,950
R01 · FY2014 · DK · contact PI
Hepcidin therapy for iron overload and hematologic disorders$553,380
R01 · FY2013 · DK
The role of erythroferrone in iron homeostasis and in iron-loading anemias$334,950
R01 · FY2013 · DK · contact PI
Bioiron 2013: From basic science to medicine$10,000
R13 · FY2013 · DK · contact PI
Hepcidin therapy for iron overload and hematologic disorders$594,013
R01 · FY2012 · DK
Hepcidin, ferroportin and iron disorders$362,245
R01 · FY2012 · DK · contact PI
Hepcidin therapy for iron overload and hematologic disorders$614,637
R01 · FY2011 · DK
Hepcidin, ferroportin and iron disorders$432,078
R01 · FY2011 · DK · contact PI
Bioiron 2011: From basic science to medicine$15,000
R13 · FY2011 · DK · contact PI
Hepcidin therapy for iron overload and hematologic disorders$787,583
R01 · FY2010 · DK
THE ROLE OF INFLAMMATION IN ANEMIA OF THE ELDERLY$385,000
R01 · FY2010 · HL · contact PI
Hepcidin, ferroportin and iron disorders$365,904
R01 · FY2010 · DK · contact PI
Hepcidin, ferroportin and iron disorders$60,064
R01 · FY2010 · DK · contact PI
THE ROLE OF INFLAMMATION IN ANEMIA OF THE ELDERLY$58,447
R01 · FY2010 · HL · contact PI
THE ROLE OF INFLAMMATION IN ANEMIA OF THE ELDERLY$29,007
M01 · FY2010 · RR · contact PI
THE ROLE OF INFLAMMATION IN ANEMIA OF THE ELDERLY$441,769
R01 · FY2009 · HL · contact PI
Hepcidin, ferroportin and iron disorders$369,600
R01 · FY2009 · DK · contact PI
THE ROLE OF INFLAMMATION IN ANEMIA OF THE ELDERLY$441,219
R01 · FY2008 · HL · contact PI
Hepcidin and Anemia of Inflammation$315,841
R01 · FY2008 · DK · contact PI
THE ROLE OF INFLAMMATION IN ANEMIA OF THE ELDERLY$28,594
R01 · FY2008 · HL · contact PI
THE ROLE OF INFLAMMATION IN ANEMIA OF THE ELDERLY$418,127
R01 · FY2007 · HL · contact PI
Hepcidin and Anemia of Inflammation$322,287
R01 · FY2007 · DK · contact PI
The role of hemojuvelin in the regulation of iron metabolism$187,524
R21 · FY2007 · DK · contact PI
Hepcidin and Anemia of Inflammation$331,912
R01 · FY2006 · DK · contact PI
The role of hemojuvelin in the regulation of iron metabolism$231,750
R21 · FY2006 · DK · contact PI
Hepcidin and Anemia of Inflammation$339,900
R01 · FY2005 · DK
Effects of IPF and its treatment on innate immunity$204,345
P50 · FY2005 · HL
Hepcidin and Anemia of Inflammation$337,700
R01 · FY2004 · DK
Human Defensins in Phagocytes and Epithelia$305,000
R01 · FY2004 · HL
INNATE HOST DEFENSE IN THE HUMAN VAGINA$278,731
R01 · FY2004 · AI
Human Defensins in Phagocytes and Epithelia$305,000
R01 · FY2003 · HL
INNATE HOST DEFENSE IN THE HUMAN VAGINA$272,136
R01 · FY2003 · AI
Human Defensins in Phagocytes and Epithelia$305,000
R01 · FY2002 · HL
INNATE HOST DEFENSE IN THE HUMAN VAGINA$212,243
R01 · FY2002 · AI
Effects of IPF and its treatment on innate immunity$182,367
P50 · FY2002 · HL
INNATE HOST DEFENSE IN THE HUMAN VAGINA$0
P01 · FY2002 · AI
Human Defensins in Phagocytes and Epithelia$306,000
R01 · FY2001 · HL
INNATE HOST DEFENSE IN THE HUMAN VAGINA$250,042
R01 · FY2001 · AI
NASAL CARRIAGE OF STAPHYLOCOCCUS AUREUS$229,500
R21 · FY2001 · AI
INNATE HOST DEFENSE IN THE HUMAN VAGINA$0
P01 · FY2001 · AI
Effects of IPF and its treatment on innate immunity$0
P01 · FY2001 · HL
PRODUCTION OF ANTIMICROBIAL PEPTIDES BY HUMAN NEUTROPHIL$267,713
R01 · FY2000 · HL
BETA-DEFENSINS IN THE FEMALE GENITAL TRACT AND KIDNEYS$254,536
R01 · FY2000 · AI
INNATE HOST DEFENSE IN THE HUMAN VAGINA$254,315
R01 · FY2000 · AI
NASAL CARRIAGE OF STAPHYLOCOCCUS AUREUS$229,500
R21 · FY2000 · AI
INNATE HOST DEFENSE IN THE HUMAN VAGINA$159,697
P01 · FY2000 · AI